How are FOXO3 and Blutzucker related?

FOXO3 is a transcription factor central to the insulin/IGF-1 signaling pathway. Under low insulin (e.g., fasting), FOXO3 becomes active and promotes hepatic gluconeogenesis, which can raise blood glucose. At the same time, FOXO3 protects against oxidative stress and is linked to longevity. The relationship with blood sugar is indirect and context-dependent: FOXO3 activity increases glucose production, but insulin suppresses it. Disruptions in this feedback (e.g., insulin resistance) can contribute to elevated blood glucose. In population genetic studies, FOXO3 variants show only weak effects on fasting glucose or diabetes risk – much smaller than genes like TCF7L2. A consumer DNA test like MyBody-X provides a probabilistic hint, not a diagnosis. Clinical relevance is limited; actual blood sugar levels and lifestyle factors are far more important. In summary, FOXO3 is mechanistically connected to glucose regulation, but common variant effects are small and not suitable for individual prediction.